Is BTMD or ACH more profitable?

biote has a net margin of 3.19% compared to Accendra Health's net margin of -11.41%. Accendra Health's return on equity of -4.02% beat biote's return on equity. Company Net Margins Return on Equity Return on Assets biote 3.19% -22.33% 12.10% Accendra Health -11.41% -4.02% 0.70%

Does the media favor BTMD or ACH?

In the previous week, Accendra Health had 1 more articles in the media than biote. MarketBeat recorded 2 mentions for Accendra Health and 1 mentions for biote. biote's average media sentiment score of 0.00 equaled Accendra Health'saverage media sentiment score. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment biote 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Accendra Health 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Do analysts prefer PRPO or ACH?

Accendra Health has a consensus target price of $1.50, suggesting a potential upside of 615.99%. Given Accendra Health's stronger consensus rating and higher possible upside, analysts clearly believe Accendra Health is more favorable than Precipio. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Precipio 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Accendra Health 2 Sell rating(s) 3 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.60

Does the media refer more to PRPO or ACH?

In the previous week, Accendra Health had 1 more articles in the media than Precipio. MarketBeat recorded 2 mentions for Accendra Health and 1 mentions for Precipio. Precipio's average media sentiment score of 0.67 beat Accendra Health's score of 0.00 indicating that Precipio is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Precipio 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Accendra Health 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Does the media refer more to ACH or PIII?

In the previous week, Accendra Health and Accendra Health both had 2 articles in the media. Accendra Health's average media sentiment score of 0.00 equaled P3 Health Partners'average media sentiment score. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Accendra Health 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral P3 Health Partners 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Do analysts recommend RYOJ or ACH?

Accendra Health has a consensus price target of $1.50, suggesting a potential upside of 615.99%. Given Accendra Health's stronger consensus rating and higher probable upside, analysts plainly believe Accendra Health is more favorable than RYOJ. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score RYOJ 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Accendra Health 2 Sell rating(s) 3 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.60

Which has stronger earnings and valuation, RYOJ or ACH?

RYOJ has higher earnings, but lower revenue than Accendra Health. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio RYOJ $9.34M 2.86 $120K N/A N/A Accendra Health $2.65B 0.01 -$1.10B -$3.91 N/A

Is ACH or DCGO more profitable?

Accendra Health has a net margin of -11.41% compared to DocGo's net margin of -65.29%. Accendra Health's return on equity of -4.02% beat DocGo's return on equity. Company Net Margins Return on Equity Return on Assets Accendra Health -11.41% -4.02% 0.70% DocGo -65.29% -40.42% -24.81%

Does the media refer more to ACH or DCGO?

In the previous week, Accendra Health had 1 more articles in the media than DocGo. MarketBeat recorded 2 mentions for Accendra Health and 1 mentions for DocGo. Accendra Health's average media sentiment score of 0.00 equaled DocGo'saverage media sentiment score. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Accendra Health 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral DocGo 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Accendra Health (ACH) Competitors

$0.21 0.00 (-0.62%)

As of 10/23/2026 03:58 PM Eastern

Compare

ACH vs. BTMD, PRPO, PIII, RYOJ, and DCGO

Should you buy Accendra Health stock or one of its competitors? Accendra Health's main competitors and comparable companies include biote (BTMD), Precipio (PRPO), P3 Health Partners (PIII), RYOJ (RYOJ), and DocGo (DCGO). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare services" industry.

How does Accendra Health compare to biote?

biote (NASDAQ:BTMD) and Accendra Health (NYSE:ACH) are both small-cap healthcare companies, but which is the better stock? We will contrast the two businesses based on the strength of their earnings, valuation, dividends, risk, profitability, media sentiment, analyst recommendations and institutional ownership.

In the previous week, Accendra Health had 1 more articles in the media than biote. MarketBeat recorded 2 mentions for Accendra Health and 1 mentions for biote. biote's average media sentiment score of 0.00 equaled Accendra Health'saverage media sentiment score.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
biote	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Accendra Health	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

biote currently has a consensus price target of $2.50, suggesting a potential upside of 133.64%. Accendra Health has a consensus price target of $1.50, suggesting a potential upside of 615.99%. Given Accendra Health's higher probable upside, analysts plainly believe Accendra Health is more favorable than biote.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
biote	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	2.50
Accendra Health	2 Sell rating(s)	3 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.60

biote has a beta of 1.69, indicating that its stock price is 69% more volatile than the broader market. Comparatively, Accendra Health has a beta of 1.57, indicating that its stock price is 57% more volatile than the broader market.

biote has higher earnings, but lower revenue than Accendra Health. Accendra Health is trading at a lower price-to-earnings ratio than biote, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
biote	$183.53M	0.21	$27.05M	$0.11	9.73
Accendra Health	$2.65B	0.01	-$1.10B	-$3.91	N/A

21.7% of biote shares are owned by institutional investors. 32.4% of biote shares are owned by company insiders. Comparatively, 2.3% of Accendra Health shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

biote has a net margin of 3.19% compared to Accendra Health's net margin of -11.41%. Accendra Health's return on equity of -4.02% beat biote's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
biote	3.19%	-22.33%	12.10%
Accendra Health	-11.41%	-4.02%	0.70%

Summary

biote beats Accendra Health on 12 of the 16 factors compared between the two stocks.

How does Accendra Health compare to Precipio?

Precipio (NASDAQ:PRPO) and Accendra Health (NYSE:ACH) are both small-cap healthcare companies, but which is the better stock? We will compare the two businesses based on the strength of their analyst recommendations, profitability, earnings, dividends, media sentiment, valuation, risk and institutional ownership.

Precipio has higher earnings, but lower revenue than Accendra Health. Precipio is trading at a lower price-to-earnings ratio than Accendra Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Precipio	$24.05M	1.49	-$360K	-$0.64	N/A
Accendra Health	$2.65B	0.01	-$1.10B	-$3.91	N/A

10.5% of Precipio shares are held by institutional investors. 16.6% of Precipio shares are held by insiders. Comparatively, 2.3% of Accendra Health shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Precipio has a beta of 1.3, indicating that its stock price is 30% more volatile than the broader market. Comparatively, Accendra Health has a beta of 1.57, indicating that its stock price is 57% more volatile than the broader market.

Accendra Health has a consensus target price of $1.50, suggesting a potential upside of 615.99%. Given Accendra Health's stronger consensus rating and higher possible upside, analysts clearly believe Accendra Health is more favorable than Precipio.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Precipio	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Accendra Health	2 Sell rating(s)	3 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.60

Precipio has a net margin of -4.47% compared to Accendra Health's net margin of -11.41%. Accendra Health's return on equity of -4.02% beat Precipio's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Precipio	-4.47%	-8.49%	-5.75%
Accendra Health	-11.41%	-4.02%	0.70%

In the previous week, Accendra Health had 1 more articles in the media than Precipio. MarketBeat recorded 2 mentions for Accendra Health and 1 mentions for Precipio. Precipio's average media sentiment score of 0.67 beat Accendra Health's score of 0.00 indicating that Precipio is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Precipio	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Accendra Health	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Summary

Accendra Health beats Precipio on 8 of the 15 factors compared between the two stocks.

How does Accendra Health compare to P3 Health Partners?

Accendra Health (NYSE:ACH) and P3 Health Partners (NASDAQ:PIII) are both small-cap healthcare companies, but which is the better investment? We will contrast the two companies based on the strength of their valuation, analyst recommendations, media sentiment, profitability, dividends, earnings, risk and institutional ownership.

In the previous week, Accendra Health and Accendra Health both had 2 articles in the media. Accendra Health's average media sentiment score of 0.00 equaled P3 Health Partners'average media sentiment score.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Accendra Health	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
P3 Health Partners	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

P3 Health Partners has lower revenue, but higher earnings than Accendra Health. P3 Health Partners is trading at a lower price-to-earnings ratio than Accendra Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Accendra Health	$2.65B	0.01	-$1.10B	-$3.91	N/A
P3 Health Partners	$1.50B	0.02	-$147.95M	-$33.00	N/A

Accendra Health currently has a consensus price target of $1.50, suggesting a potential upside of 615.99%. P3 Health Partners has a consensus price target of $17.00, suggesting a potential upside of 310.63%. Given Accendra Health's higher probable upside, equities research analysts plainly believe Accendra Health is more favorable than P3 Health Partners.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Accendra Health	2 Sell rating(s)	3 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.60
P3 Health Partners	1 Sell rating(s)	2 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

Accendra Health has a beta of 1.57, indicating that its share price is 57% more volatile than the broader market. Comparatively, P3 Health Partners has a beta of 1.7, indicating that its share price is 70% more volatile than the broader market.

P3 Health Partners has a net margin of -6.55% compared to Accendra Health's net margin of -11.41%. P3 Health Partners' return on equity of 0.00% beat Accendra Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Accendra Health	-11.41%	-4.02%	0.70%
P3 Health Partners	-6.55%	N/A	-16.40%

7.8% of P3 Health Partners shares are held by institutional investors. 2.3% of Accendra Health shares are held by company insiders. Comparatively, 10.9% of P3 Health Partners shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Summary

P3 Health Partners beats Accendra Health on 9 of the 14 factors compared between the two stocks.

How does Accendra Health compare to RYOJ?

RYOJ (NASDAQ:RYOJ) and Accendra Health (NYSE:ACH) are both small-cap healthcare companies, but which is the superior business? We will compare the two businesses based on the strength of their valuation, earnings, dividends, risk, media sentiment, profitability, analyst recommendations and institutional ownership.

In the previous week, Accendra Health had 2 more articles in the media than RYOJ. MarketBeat recorded 2 mentions for Accendra Health and 0 mentions for RYOJ. RYOJ's average media sentiment score of 0.00 equaled Accendra Health'saverage media sentiment score.

Company	Overall Sentiment
RYOJ	Neutral
Accendra Health	Neutral

RYOJ has a beta of 4.54, meaning that its stock price is 354% more volatile than the broader market. Comparatively, Accendra Health has a beta of 1.57, meaning that its stock price is 57% more volatile than the broader market.

Accendra Health has a consensus price target of $1.50, suggesting a potential upside of 615.99%. Given Accendra Health's stronger consensus rating and higher probable upside, analysts plainly believe Accendra Health is more favorable than RYOJ.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
RYOJ	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Accendra Health	2 Sell rating(s)	3 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.60

RYOJ has a net margin of 0.00% compared to Accendra Health's net margin of -11.41%. RYOJ's return on equity of 0.00% beat Accendra Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
RYOJ	N/A	N/A	N/A
Accendra Health	-11.41%	-4.02%	0.70%

RYOJ has higher earnings, but lower revenue than Accendra Health.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
RYOJ	$9.34M	2.86	$120K	N/A	N/A
Accendra Health	$2.65B	0.01	-$1.10B	-$3.91	N/A

Summary

RYOJ and Accendra Health tied by winning 5 of the 10 factors compared between the two stocks.

How does Accendra Health compare to DocGo?

Accendra Health (NYSE:ACH) and DocGo (NASDAQ:DCGO) are both small-cap healthcare companies, but which is the superior business? We will contrast the two companies based on the strength of their analyst recommendations, profitability, media sentiment, dividends, risk, valuation, earnings and institutional ownership.

In the previous week, Accendra Health had 1 more articles in the media than DocGo. MarketBeat recorded 2 mentions for Accendra Health and 1 mentions for DocGo. Accendra Health's average media sentiment score of 0.00 equaled DocGo'saverage media sentiment score.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Accendra Health	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
DocGo	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

56.4% of DocGo shares are held by institutional investors. 2.3% of Accendra Health shares are held by insiders. Comparatively, 5.1% of DocGo shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

DocGo has lower revenue, but higher earnings than Accendra Health. DocGo is trading at a lower price-to-earnings ratio than Accendra Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Accendra Health	$2.65B	0.01	-$1.10B	-$3.91	N/A
DocGo	$294.72M	0.09	-$182.40M	-$1.96	N/A

Accendra Health has a beta of 1.57, indicating that its stock price is 57% more volatile than the broader market. Comparatively, DocGo has a beta of 0.97, indicating that its stock price is 3% less volatile than the broader market.

Accendra Health presently has a consensus target price of $1.50, suggesting a potential upside of 615.99%. DocGo has a consensus target price of $2.38, suggesting a potential upside of 775.41%. Given DocGo's stronger consensus rating and higher possible upside, analysts plainly believe DocGo is more favorable than Accendra Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Accendra Health	2 Sell rating(s)	3 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.60
DocGo	1 Sell rating(s)	2 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.33

Accendra Health has a net margin of -11.41% compared to DocGo's net margin of -65.29%. Accendra Health's return on equity of -4.02% beat DocGo's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Accendra Health	-11.41%	-4.02%	0.70%
DocGo	-65.29%	-40.42%	-24.81%

Summary

DocGo beats Accendra Health on 8 of the 15 factors compared between the two stocks.

Get Accendra Health News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ACH and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

ACH vs. The Competition

Export

Metric	Accendra Health	Healthcare Providers & Services Industry	Healthcare Sector	NYSE Exchange
Market Cap	$16.71M	$10.54B	$7.59B	$23.23B
Dividend Yield	N/A	2.56%	2.48%	3.66%
P/E Ratio	-0.05	34.31	271.05	28.19
Price / Sales	0.01	5.44	665.27	77.95
Price / Cash	0.06	110.70	76.01	32.59
Price / Book	-0.04	5.12	10.62	4.71
Net Income	-$1.10B	$315.68M	$3.51B	$1.07B
7 Day Performance	-8.11%	1.19%	1.17%	0.41%
1 Month Performance	-70.65%	-2.64%	-7.13%	-0.99%
1 Year Performance	N/A	15.63%	1.60%	4.89%

Accendra Health Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
ACH Accendra Health	2.0775 of 5 stars	$0.21 -0.6%	$1.50 +616.0%	N/A	$16.71M	$2.65B	N/A	6,500	News Coverage Gap Down
BTMD biote	4.4245 of 5 stars	$1.11 +7.3%	$2.50 +126.2%	-63.0%	$39.70M	$183.53M	10.05	223	Gap Up
PRPO Precipio	0.971 of 5 stars	$20.56 -3.2%	N/A	-2.6%	$36.80M	$27.20M	N/A	71	News Coverage
PIII P3 Health Partners	2.2639 of 5 stars	$4.38 +6.4%	$17.00 +288.6%	-53.2%	$31.77M	$1.50B	N/A	320	News Coverage Gap Down
RYOJ RYOJ	N/A	$2.47 -2.2%	N/A	N/A	$28.47M	$9.34M	N/A	313

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NYSE:ACH) was last updated on 10/25/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Accendra Health (ACH) Competitors

ACH vs. BTMD, PRPO, PIII, RYOJ, and DCGO

How does Accendra Health compare to biote?

Summary

How does Accendra Health compare to Precipio?

Summary

How does Accendra Health compare to P3 Health Partners?

Summary

How does Accendra Health compare to RYOJ?

Summary

How does Accendra Health compare to DocGo?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

ACH vs. The Competition

Accendra Health Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Accendra Health (ACH) Competitors

ACH vs. BTMD, PRPO, PIII, RYOJ, and DCGO

How does Accendra Health compare to biote?

Does the media favor BTMD or ACH?

Do analysts rate BTMD or ACH?

Which has more volatility and risk, BTMD or ACH?

Which has better valuation and earnings, BTMD or ACH?

Do insiders and institutionals hold more shares of BTMD or ACH?

Is BTMD or ACH more profitable?

Summary

How does Accendra Health compare to Precipio?

Which has preferable earnings and valuation, PRPO or ACH?

Do institutionals & insiders hold more shares of PRPO or ACH?

Which has more risk and volatility, PRPO or ACH?

Do analysts prefer PRPO or ACH?

Is PRPO or ACH more profitable?

Does the media refer more to PRPO or ACH?

Summary

How does Accendra Health compare to P3 Health Partners?

Does the media refer more to ACH or PIII?

Which has stronger valuation and earnings, ACH or PIII?

Do analysts prefer ACH or PIII?

Which has more volatility and risk, ACH or PIII?

Is ACH or PIII more profitable?

Do institutionals and insiders hold more shares of ACH or PIII?

Summary

How does Accendra Health compare to RYOJ?

Does the media prefer RYOJ or ACH?

Which has more volatility & risk, RYOJ or ACH?

Do analysts recommend RYOJ or ACH?

Is RYOJ or ACH more profitable?

Which has stronger earnings and valuation, RYOJ or ACH?

Summary

How does Accendra Health compare to DocGo?

Does the media refer more to ACH or DCGO?

Do insiders & institutionals hold more shares of ACH or DCGO?

Which has higher earnings and valuation, ACH or DCGO?

Which has more risk and volatility, ACH or DCGO?

Do analysts prefer ACH or DCGO?

Is ACH or DCGO more profitable?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

ACH vs. The Competition

Accendra Health Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools